A clause limiting the use of multiyear NIH grant funding has become a sticking point as the Senate appropriations panel ...

The Supreme Court agreed to review a controversy over so-called skinny labels for medicines, a decision that will be closely ...

Reported measles cases in South Carolina surged by almost 30% in the last few days, state health officials said Friday.

Today, we discuss Trump’s lofty new health plan, see the FDA delay two drug reviews under the new voucher program, and more.

Some major drugmakers are hesitating to participate in the Trump administration's speedier review program for new medicines ...

Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. Here’s our web archive of the free email newsletter ...

After getting demolished by the flu last week, I am thrilled to be back in the saddle. Stay healthy, everyone! President ...

This is the online version of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to ...

When the new U.S. dietary guidelines came out last week, food economist William Masters emailed a few colleagues with a fun ...

The actual “how” of lifestyle medicine — meeting patients where they are, outside of the exam room — is crowded out of the ...